Answers are grounded in this paper and cite their sources.
Investigation reveals mixed coreceptor usage in HIV-1 among PWID, suggesting implications for treatment strategies.
Background Our previous study suggested that mixed infection with R5 and X4/dual human immunodeficiency virus-1 (HIV-1) may contribute to coreceptor switch from R5 to X4 HIV-1. To confirm this hypothesis, we investigated mixed HIV-1 infections in people who inject drugs (PWID) infected with the CRF01_AE subtype. Methods Viral plasma RNA from PWID were extracted, the V3 region of the HIV-1 gp120 gene was amplified and deep sequencing was performed. Coreceptor usage was determined using phenotypic assay by cloning each V3 region. Coreceptor usage of minor HIV-1 variants detected by deep sequencing was predicted based on the amino acid sequences of the V3 region. Results Deep sequencing of plasma from 36 PWID revealed that mixed HIV-1 infection involving different coreceptor usage occurred in 13 cases (36.1%). Phylogenetic analysis revealed that R5 variants were dominant, whereas X4/dual variants were detected as minor populations in most cases. In one case, however, R5 variants emerged as a distinct minor population mixed with X4/dual variants as the major population. Notably, plasma viral RNA load (pVL) was higher in cases of mixed infection with R5 and X4/dual HIV-1 than those infected solely with R5 HIV-1. Conclusions Our observations suggest a possible association between mixed HIV-1 coreceptor usage and coreceptor switch in CRF01_AE–infected PWID, and that mixed infection may be associated with pVL.
No takes yet. Share an insight, caveat, or question.
Maeda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: